Clinical Trials Browser

Phase 2 × rindopepimut × Sarcoma × Clear all

NCT01498328 2020-02-17

ReACT

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma